Drug or food anaphylaxis?

Main Article Content

Catalina Gomez-Galán
Bélgica Minaya-Polanco
Jiménez-Freites Martha
Julián Andrés Manrique Niño
Adrianna Machinena-Spera

Keywords

anaphylaxis, adrenaline, casein, pharmacovigilance, iron protein succinylate

Abstract

A 9-month-old infant with a personal history of atopic dermatitis and no family history of atopy presented to the outpatient allergy clinic for evaluation of suspected food and drug allergy. The mother breastfed the infant from birth and had introduced only fruits and vegetables into his diet. After the first dose of Ferplex® (iron protein succinylate), the infant had an immediate moderate systemic reaction that required emergency care and treatment with intramuscular epinephrine. The drug was indicated for the treatment of acute anemia. Skin prick test and specific IgE were done, confirming sensitization to cow’s milk and egg proteins. It was determined that the baby was sensitized to cow’s milk proteins, without prior ingestion, and experienced an anaphylactic reaction after taking Ferplex®, a pharmaceutical product that contains casein as part of its active ingredients. The presence of succinylated casein was confirmed, without pertinent information on the amount in the technical sheet or package insert. Existing pharmaceutical industry regulations should be modified in order to declare food allergens present in excipients and in active ingredients to avoid potential risks for allergic patients. A detailed food history is important in young children who are gradually being introduced to new foods, and in those that have not yet been introduced, recordings should be made to avoid this type of allergic reaction.

Abstract 147 | PDF Downloads 175 HTML Downloads 0 XML Downloads 1

References

1 Valdesoiro Navarrete L, Vila Sexto L. IgE-mediated food allergy. Diagnostic protocol pediatr. 2019;2: 185–94.

2 Regulation 1169/2011 on food information provided to the consumer. Spanish Food Safety Agency. AESAN. Government of Spain. Food safety Official Journal of the European Union 22.11.2011.

3 Circular 2/2008, de Instrucción sobre excipientes. Agencia española de medicamentos y productos sanitarios. (Listado de excipientes de declaración obligatoria).

4 Resolution of September 24, 2021, of the Spanish Agency of Medicines and Health Products, by which instructions on excipients are issued in the information of the medicines. BOE »no. 253, of October 22, 2021, pages 128761 to 128765. https://www.boe.es/eli/es/res/2021/09/24/(2)

5 Ruth Aparicio Hernández. 2nd year resident of Clinical Pharmacology. Gómez-Ulla Central Defense Hospital. Food and drug allergy. Adverse drug reactions. Informative bulletin of the Pharmacovigilance center of the community of Madrid. Volume 22/No. 3/November 2015.

6 Ferplex 40 mg Oral Solution. Technical data. Italfarmaco SA. Spain. Date of first authorization: February 1993. Date of last renewal: October 2007. Date of revision of the text: March 2020.

7 Medicines with potential hypersensitivity problems in relation to food additives. Document prepared by the drug allergy committee of the SPANISH SOCIETY OF ALLERGY AND CLINICAL IMMUNOLOGY (SEAIC) November 10, 2010.

8 Larramendi CH, Marco FM, García-Abujeta JL, Mateo M, de la Vega A, Sempere JM. Acute allergic reaction to an iron compound in a milk-allergic patient. Pediatr Allergy Immunol 2006;17:230–330. 10.1111/j.1399-3038.2005.00373.x